Material Type

• Blood (whole) (1)
• Buffy coat (1)
• Cerebrospinal fluid (1)
• Dried whole blood (1)
• Isolated peripheral blood mononuclear cells (viable) (1)
• Pathogen DNA (Derivative) (1)
• Plasma (double spun) (1)
• Plasma (single spun) (3)
• Saliva (1)
• Serum (4)
• Stool (1)
• Urine (random) (2)

Microscopic Assessment

• Affected (1)
• Not applicable (5)

Storage Temperature

• RT (1)
• -35°C to -18°C (2)
• -85°C to -60°C (4)
• Liquid nitrogen (1)

Associated Data

• Biomarker datasets (2)
• Clinical records (4)
• Followup records (3)
• Freezer temperature logs (2)
• Genomic datasets (1)
• Imaging data (1)
• Microbiological results (2)
• Participant Ethnicity (2)
• Physiological/biochemical measurements (1)
• Pre-analytical data (2)
• Primary care records (1)
• Quality indicators (1)
• Survey data (2)
• Treatment records (2)

Timeframe

• Immediate (1)
• 0 - 3 months (4)
• 3 - 6 months (2)
• > 6 months (2)

Participant Count

• 1 - 10 (1)
• 11 - 100 (3)
• 101 - 500 (4)
• 1001 - 3000 (1)

Sex

• Female (1)
• Both sexes (6)

Age Range

• Young adult (18 - 40 years) (6)

Biobank Services

• Cell culture (1)
• Molecular Extractions (1)
• Nucleic acid extraction (1)

Collection Type

• Case-control (3)
• Cohort (1)
• Cross-sectional (2)
• Disease specific (2)

Consent Restriction

• No Commercial restriction (5)
• No Disease area restriction (6)
• No Genetic analysis restriction (4)
• No Human genetic analysis restriction (6)
• No restrictions (3)
• No Project specific restriction (6)
• No Scope of use restriction (6)

Collection Status

• Completed (3)
• In progress (3)
• Not-started (1)

Access Condition

• Open to applicants (3)
• Open only through collaboration (1)
• Access restricted at present (2)

Country

• Belgium (1)
• Brazil (1)
• France (1)
• Kenya (1)
• Uganda (1)
• United States (1)

County